ArticleBMC ophthalmology2026
Short-term outcomes of selective laser trabeculoplasty in pseudophakic primary angle-closure glaucoma after iridotomy: a retrospective pilot comparison with primary open-angle glaucoma.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSelective laser trabeculoplasty (SLT) is a widely accepted treatment for primary open-angle glaucoma (POAG), but its role in primary angle-closure glaucoma (PACG) remains less defined. This study aimed to evaluate the short-term outcomes of SLT in pseudophakic PACG patients who had undergone prior laser peripheral iridotomy (LPI), and to compare outcomes with those in POAG patients.
methodsThis retrospective study included pseudophakic patients diagnosed with PACG after LPI or POAG who underwent SLT. Intraocular pressure (IOP) and topical antiglaucoma medication use were assessed at baseline and at 1, 2, and 3 months after SLT. Changes in IOP over time were analyzed, and multivariable linear regression was performed to evaluate factors associated with IOP reduction at 1 month.
resultsA total of 123 patients were included, comprising 89 with POAG and 34 with PACG. The PACG group was older and had a higher proportion of female patients. The mean IOP reduction was numerically comparable between groups at each follow-up visit. At 1 month, a statistically significant reduction in IOP was observed in the POAG group. The PACG group also demonstrated a numerical reduction in IOP, although this did not reach statistical significance. However, the between-group comparison at 1 month should be interpreted cautiously given the limited sample size and multiple comparisons. The number of glaucoma medications remained unchanged during the follow-up period in both groups. In multivariable analysis, baseline IOP was associated with greater IOP reduction at 1 month, whereas SLT energy parameters were not significantly associated with treatment response. No major complications were recorded during the study period.
conclusionsSLT demonstrated a short-term IOP-lowering effect in pseudophakic PACG after LPI, with outcomes numerically similar to those in pseudophakic POAG. These findings should be considered preliminary and warrant confirmation in larger prospective studies with longer follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.